Ligan, Gilmhar B.
HRN: 24-18-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/11/2023
12/18/2023
IV
300mg
1 Hour PTOR Then Q8hr
Panfacial Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes